STAAR SURGICAL CO (STAA) Fundamental Analysis & Valuation

NASDAQ:STAA • US8523123052

Current stock price

25.67 USD
+0.83 (+3.34%)
At close:
25.67 USD
0 (0%)
After Hours:

This STAA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. STAA Profitability Analysis

1.1 Basic Checks

  • In the past year STAA has reported negative net income.
  • In the past year STAA has reported a negative cash flow from operations.
  • In multiple years STAA reported negative net income over the last 5 years.
  • Of the past 5 years STAA 4 years had a positive operating cash flow.
STAA Yearly Net Income VS EBIT VS OCF VS FCFSTAA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

  • STAA has a Return On Assets (-17.81%) which is comparable to the rest of the industry.
  • STAA has a Return On Equity of -23.37%. This is comparable to the rest of the industry: STAA outperforms 58.82% of its industry peers.
Industry RankSector Rank
ROA -17.81%
ROE -23.37%
ROIC N/A
ROA(3y)-5.8%
ROA(5y)-0.19%
ROE(3y)-7.64%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
STAA Yearly ROA, ROE, ROICSTAA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • With an excellent Gross Margin value of 76.19%, STAA belongs to the best of the industry, outperforming 86.10% of the companies in the same industry.
  • In the last couple of years the Gross Margin of STAA has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for STAA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y1.02%
STAA Yearly Profit, Operating, Gross MarginsSTAA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. STAA Health Analysis

2.1 Basic Checks

  • STAA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for STAA has been increased compared to 1 year ago.
  • STAA has more shares outstanding than it did 5 years ago.
  • STAA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
STAA Yearly Shares OutstandingSTAA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
STAA Yearly Total Debt VS Total AssetsSTAA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 7.25 indicates that STAA is not in any danger for bankruptcy at the moment.
  • STAA has a better Altman-Z score (7.25) than 82.89% of its industry peers.
  • There is no outstanding debt for STAA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.25
ROIC/WACCN/A
WACC8.96%
STAA Yearly LT Debt VS Equity VS FCFSTAA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • STAA has a Current Ratio of 4.55. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of STAA (4.55) is better than 70.59% of its industry peers.
  • A Quick Ratio of 3.74 indicates that STAA has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 3.74, STAA is doing good in the industry, outperforming 71.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 3.74
STAA Yearly Current Assets VS Current LiabilitesSTAA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. STAA Growth Analysis

3.1 Past

  • The earnings per share for STAA have decreased strongly by -421.21% in the last year.
  • STAA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.72%.
  • The Revenue has been growing slightly by 7.93% on average over the past years.
EPS 1Y (TTM)-421.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26%
Revenue 1Y (TTM)-23.72%
Revenue growth 3Y-5.57%
Revenue growth 5Y7.93%
Sales Q2Q%18.08%

3.2 Future

  • STAA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.48% yearly.
  • The Revenue is expected to grow by 13.36% on average over the next years. This is quite good.
EPS Next Y93.81%
EPS Next 2Y48.89%
EPS Next 3Y32.03%
EPS Next 5Y34.48%
Revenue Next Year19.25%
Revenue Next 2Y13.7%
Revenue Next 3Y11.78%
Revenue Next 5Y13.36%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STAA Yearly Revenue VS EstimatesSTAA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
STAA Yearly EPS VS EstimatesSTAA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. STAA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for STAA. In the last year negative earnings were reported.
  • Also next year STAA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STAA Price Earnings VS Forward Price EarningsSTAA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STAA Per share dataSTAA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as STAA's earnings are expected to grow with 32.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.89%
EPS Next 3Y32.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STAA Dividend Analysis

5.1 Amount

  • STAA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STAA Fundamentals: All Metrics, Ratios and Statistics

STAAR SURGICAL CO

NASDAQ:STAA (4/24/2026, 8:09:37 PM)

After market: 25.67 0 (0%)

25.67

+0.83 (+3.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-03
Earnings (Next)05-06
Inst Owners110.46%
Inst Owner Change-0.05%
Ins Owners0.41%
Ins Owner Change15.72%
Market Cap1.27B
Revenue(TTM)239.44M
Net Income(TTM)-80.45M
Analysts69.41
Price Target20.97 (-18.31%)
Short Float %15.72%
Short Ratio5.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-362.76%
Min EPS beat(2)-734.84%
Max EPS beat(2)9.32%
EPS beat(4)3
Avg EPS beat(4)-165.83%
Min EPS beat(4)-734.84%
Max EPS beat(4)49.58%
EPS beat(8)6
Avg EPS beat(8)-476.9%
EPS beat(12)8
Avg EPS beat(12)-310.53%
EPS beat(16)12
Avg EPS beat(16)-209.31%
Revenue beat(2)1
Avg Revenue beat(2)-11.28%
Min Revenue beat(2)-24.81%
Max Revenue beat(2)2.26%
Revenue beat(4)3
Avg Revenue beat(4)-2.67%
Min Revenue beat(4)-24.81%
Max Revenue beat(4)8.25%
Revenue beat(8)5
Avg Revenue beat(8)-5.77%
Revenue beat(12)6
Avg Revenue beat(12)-3.68%
Revenue beat(16)7
Avg Revenue beat(16)-2.83%
PT rev (1m)-9.42%
PT rev (3m)-18.79%
EPS NQ rev (1m)46.31%
EPS NQ rev (3m)35.24%
EPS NY rev (1m)-146.4%
EPS NY rev (3m)-219.06%
Revenue NQ rev (1m)13.05%
Revenue NQ rev (3m)12.28%
Revenue NY rev (1m)2.97%
Revenue NY rev (3m)-2.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.31
P/FCF N/A
P/OCF N/A
P/B 3.69
P/tB 4.08
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS4.84
BVpS6.95
TBVpS6.3
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -17.81%
ROE -23.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.19%
FCFM N/A
ROA(3y)-5.8%
ROA(5y)-0.19%
ROE(3y)-7.64%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y1.02%
F-Score3
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.68%
Cap/Sales 2.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 3.74
Altman-Z 7.25
F-Score3
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)253.71%
Cap/Depr(5y)307.54%
Cap/Sales(3y)5.17%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-421.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26%
EPS Next Y93.81%
EPS Next 2Y48.89%
EPS Next 3Y32.03%
EPS Next 5Y34.48%
Revenue 1Y (TTM)-23.72%
Revenue growth 3Y-5.57%
Revenue growth 5Y7.93%
Sales Q2Q%18.08%
Revenue Next Year19.25%
Revenue Next 2Y13.7%
Revenue Next 3Y11.78%
Revenue Next 5Y13.36%
EBIT growth 1Y-264.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year151.79%
EBIT Next 3Y38.03%
EBIT Next 5Y27.01%
FCF growth 1Y-422.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-317.68%
OCF growth 3YN/A
OCF growth 5YN/A

STAAR SURGICAL CO / STAA Fundamental Analysis FAQ

What is the fundamental rating for STAA stock?

ChartMill assigns a fundamental rating of 4 / 10 to STAA.


What is the valuation status of STAAR SURGICAL CO (STAA) stock?

ChartMill assigns a valuation rating of 1 / 10 to STAAR SURGICAL CO (STAA). This can be considered as Overvalued.


How profitable is STAAR SURGICAL CO (STAA) stock?

STAAR SURGICAL CO (STAA) has a profitability rating of 2 / 10.


Can you provide the financial health for STAA stock?

The financial health rating of STAAR SURGICAL CO (STAA) is 8 / 10.